You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anlotinib

Showing 1 - 25 of 116
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Metastatic Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Sep 18, 2023

Cervical Cancer Trial in Wuhan (Cadonilimab, Anlotinib)

Recruiting
  • Cervical Cancer
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Apr 5, 2023

Soft Tissue Sarcoma, High Risk of Recurrence, Anlotinib Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Soft Tissue Sarcoma
  • +3 more
  • Anlotinib
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 1, 2022

Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)

Recruiting
  • Extensive Stage Small Cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 6, 2023

Interstitial Lung Diseases Trial in Wenzhou (Anlotinib, Placebo)

Recruiting
  • Interstitial Lung Diseases
  • Anlotinib
  • Placebo
  • Wenzhou, Zhejiang, China
    The First Affiliated Hospital of Wenzhou Medical University
Apr 13, 2023

Thyroid Cancer Trial in Chengdu (Tislelizumab, Anlotinib, Radiotherapy)

Recruiting
  • Thyroid Cancer
  • Chengdu, Sichuan, China
    Xingchen Peng
Dec 17, 2022

Breast Cancer Stage II Trial in Xi'an (Anlotinib)

Recruiting
  • Breast Cancer Stage II
  • Anlotinib
  • Xi'an, Shannxi Province, China
    Xijing Hospital Affiliated to Air Force Military Medical Univers
Sep 25, 2022

Lung Cancer, TKI Resistance, EGFR Sensitive Mutation Trial (Anlotinib, Penpulimab)

Not yet recruiting
  • Lung Cancer
  • +4 more
  • (no location specified)
Sep 15, 2023

Desmoid Trial in Zhengzhou (Anlotinib)

Not yet recruiting
  • Desmoid
  • Anlotinib
  • Zhengzhou, Henan, China
    Department of Bone and Soft Tissue ,Henan Cancer Hospital
Aug 4, 2022

Pancreatic Tumors Trial in Nanjing (Penpulimab, Anlotinib, Nab paclitaxel)

Recruiting
  • Pancreatic Neoplasms
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Aug 10, 2022

Metastatic Breast Cancer Trial in Changsha (Eribulin Mesylate, Anlotinib)

Recruiting
  • Metastatic Breast Cancer
  • Eribulin Mesylate
  • Anlotinib
  • Changsha, Hunan, China
    Hunan Cancer Hospital
May 4, 2022

Anlotinib Retrospective Study for Esophageal Cancer

Completed
  • Esophageal Neoplasms
  • Anlotinib
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Mar 27, 2022

NSCLC Trial (Sintilimab, Anlotinib)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Mar 23, 2022

Locally Advanced NSCLC, Efficacy and Safety Trial in Guangzhou (Anlotinib, Chemotherapy, Radiotherapy)

Recruiting
  • Locally Advanced Non-small Cell Lung Cancer
  • Efficacy and Safety
  • Anlotinib
  • +3 more
  • Guangzhou, Guangdong, China
    Sun yat-sen University Cancer Center
Jul 28, 2022

Stage IV Esophagus Squamous Cell Carcinoma Trial in Hangzhou (Camrelizumab, Irinotecan, Paclitaxel)

Not yet recruiting
  • Stage IV Esophagus Squamous Cell Carcinoma
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Apr 2, 2022

NSCLC Trial (Anlotinib)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Anlotinib
  • (no location specified)
Jan 19, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Anlotinib, Penpulimab, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer
  • Anlotinib
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 15, 2022

NSCLC Stage IV, NSCLC Stage IIIB, NSCLC Stage IIIC Trial in China (Cadonilimab, Anlotinib, Docetaxel)

Recruiting
  • NSCLC Stage IV
  • +2 more
  • Hefei, Anhui, China
  • +4 more
Apr 15, 2023

Colorectal Cancer Trial in China (Anlotinib, Penpulimab)

Recruiting
  • Colorectal Cancer
  • Beijing, Beijing, China
  • +7 more
Mar 6, 2022

Gastric Cancer Trial in Hangzhou (TAS 102, Anlotinib)

Recruiting
  • Gastric Cancer
  • TAS 102
  • Anlotinib
  • Hangzhou, Zhejiang, China
    First affiliated hospital, Zhejiang University
Dec 20, 2021

Gynecological Cancer Trial in Beijing, Chengdu (Penpulimab, Anlotinib)

Not yet recruiting
  • Gynecological Cancer
  • Beijing, Beijing, China
  • +1 more
Dec 28, 2021

NSCLC Trial in Wuhan (Toripalimab, Anlotinib, SBRT 7Gy??5 QD)

Recruiting
  • NSCLC
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Nov 29, 2021

Non Small Cell Lung Cancer Trial in Shanghai (Trametinib, Anlotinib)

Recruiting
  • Non Small Cell Lung Cancer
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Jan 16, 2022

Advanced or Metastatic Paraganglioma/ Pheochromocytoma Trial in Nanjing (Anlotinib)

Recruiting
  • Advanced or Metastatic Paraganglioma/ Pheochromocytoma
  • Anlotinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical Univerity
Nov 17, 2021

Urothelial Carcinoma, Anlotinib, Urogenital Tumors Trial in Tianjin (Anlotinib, Cisplatin, Carboplatin)

Not yet recruiting
  • Urothelial Carcinoma
  • +6 more
  • Anlotinib
  • +3 more
  • Tianjin, China
    Tianjin Medical Unversity Second Hospital
Aug 30, 2021